BL1243 (tonabersat) is being developed as a potential oral treatment for patients with earlier-stage dry AMD, where treatment options remain limited Clinical development program expected to begin in 2027 VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced […]
A study by the University of Oulu has found that women who entered menopause earlier than usual reported more symptoms of anxiety and depression than women of the same age who had not yet entered…
Kenya’s first confirmed Ebola case has turned President William Ruto’s much-debated preparedness programme into a real-world test, months after his administration defended a US-backed plan to…
(MedPage Today) -- A three-drug combination may be effective for patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) who progressed on a third-generation EGFR tyrosine kinase…
A small pilot study led by a Rutgers researcher has found differences in blood proteins between people experiencing high and low levels of pain from sickle cell disease, findings that may inform…
Nearly half a century has passed since the first recognized case of AIDS in the U.K. in December 1981. During that time, perceptions of HIV and people living with HIV have been transformed by medical…
